Wipro
270 Case Studies
A Wipro Case Study
The client, a big pharma company based in New York, faced the challenge of ensuring the health outcomes and repeat prescriptions for its new specialty nephrology drug. Wipro was engaged to develop a solution that would engage physicians and patients to guarantee the drug's efficacy and safety post-renal transplant, thereby protecting its profitability and market share.
Wipro implemented a secure, platform-independent mobile application that qualified as a Class I medical device. The solution provided physicians with tools for vital analysis, dosage calculation, and instant access to drug information, all integrated via the cloud with the client's in-house systems. This resulted in a 30% increase in revenue from a 2.5 million patient base, assured health outcomes by reducing post-transplant risks, and improved overall drug adherence and physician engagement.
Big Pharma Company